Rejuran vs Juvelook for Skin Over 40
Quick answer
Rejuran and Juvelook are different injectable product families. Rejuran is associated with polynucleotide treatment, while Juvelook products use PDLLA with hyaluronic acid. The choice should follow the exact product, treatment area and goal. Neither should be described as a guaranteed lift or a universal solution for aging skin.
Clarify what skin improvement means to you
Dryness, fine lines, visible pores and a hollow cheek are not interchangeable problems. Ask which feature the proposed injection is intended to change. If the main issue is facial volume loss, a treatment selected for surface quality may not provide the structural change you expect. If the main issue is irritation, establish the cause before adding injections.
Ask for the exact formulation
Do not accept a comparison that treats every Rejuran or Juvelook variant as identical. In particular, standard Juvelook and Juvelook Volume should not be assumed to have the same treatment purpose or protocol. Request the product name on the packaging and the proposed amount and areas. Keep these details in your treatment record for future care.
Separate emerging evidence from promises
Research on injectable skin-quality treatments is growing, but study populations, products and outcome measures differ. A recent comparative trial concerned Juvelook Volume and Sculptra for nasolabial folds; it does not establish the best injectable for every skin concern after 40. Ask what evidence supports the particular benefit being offered to you.
Plan for injection recovery
Discuss visible bumps, bruising, swelling, infection risk and the possibility of persistent lumps before booking. Ask who to contact if a problem develops after you leave Korea. Do not assume that a product can be removed as easily as a hyaluronic acid filler. A staged plan should identify why another session is needed and how the first response will be reviewed.
Frequently asked questions
Is Juvelook always better for collagen than Rejuran?
A broad superiority claim is not justified for every patient or outcome. The exact product and clinical goal need to be specified.
Can either treatment replace a facelift?
No. Injectable skin-quality treatment should not be expected to reposition substantial sagging tissue.
Sources and further reading
2026 randomized comparison of Juvelook Volume and Sculptra
Published survey of polynucleotide injection practices
Educational guide. Product availability and treatment suitability require an individual assessment. Editorial photographs illustrate skincare and do not show treatment outcomes.
